Table 3 Comparison of parameters between patients who developed CKD stage 3 vs those who did not develop CKD stage 3
| Â | Did not develop CKD stage 3 | Developed CKD stage 3 | Z/c2 | P | |
|---|---|---|---|---|---|
n = 81 | n = 91 | ||||
Sex | Male | 54 (66.7%) | 56 (61.5%) | 0.489 | 0.484 |
Female | 27 (33.3%) | 35 (38.6%) | |||
Age (years) |  | 52 (45–61) | 62 (52–70) | −4.026 | < 0.001 |
Duration after nephrectomy (years) |  | 4 (3–13) | 6 (2–15) | −0.947 | 0.344 |
Serum creatinine (μmol/L) |  | 89 (72–104) | 145 (117–330) | −9.761 | < 0.001 |
eGFR (ml/min/1.73 m2) |  | 81.9 ± 13.7 | 31.2 ± 19.7 | −11.306 | < 0.001 |
Kidney location | Left | 38 (46.9%) | 51 (56.0%) | 1.349 | 0.245 |
Right | 43 (53.1%) | 40 (44.0%) | |||
Cause of ASK | Tumors | 47 (58%) | 25 (27.5%) | 25.407 | < 0.001 |
Tuberculosis | 10 (12.3%) | 40 (44%) | Â | ||
Trauma | 4 (4.9%) | 3 (3.3%) | Â | ||
Other | 6 (7.4%) | 10 (11%) | Â | ||
Unknown | 14 (17.3%) | 13 (14.3%) | Â | ||
Current smoker | No | 63 (77.8%) | 69 (75.8%) | 0.092 | 0.762 |
Yes | 18 (22.2%) | 22 (24.2%) | |||
History of CVD | No | 73 (90.1%) | 60 (65.9%) | 14.302 | < 0.001 |
Yes | 8 (9.9%) | 31 (34.1%) | |||
Hypertension | No | 42 (52.5%) | 38 (43.2%) | 1.459 | 0.227 |
Yes | 38 (47.5%) | 50 (56.8%) | |||
Obesity | No | 50 (69.4%) | 53 (63.9%) | 0.54 | 0.462 |
Yes | 22 (30.6%) | 30 (36.1%) | |||
Diabetes | No | 67 (88.2%) | 51 (59.3%) | 18.847 | < 0.001 |
Yes | 9 (11.8%) | 35 (40.7%) | |||
Hyperuricemia | No | 62 (77.5%) | 48 (53.9%) | 10.298 | 0.001 |
Yes | 18 (22.5%) | 41 (46.1%) | |||
Dyslipidemia | No | 54 (77.5%) | 71 (88.8%) | 1.411 | 0.235 |
yes | 12 (22.5%) | 9 (11.2%) | |||